Evidence map›Paper›PMID 32642566›Full record

ArticleeNeurologicalSci2020

Endothelial dysfunction and carotid atherosclerosis in Malawian adults: A cross-sectional study.

Joseph Kamtchum-Tatuene, Gloria Mwangalika Kachingwe, Henry C Mwandumba, Tom Solomon, Laura A Benjamin

Open access · goldAbstract read
In one paragraph

Article in eNeurologicalSci, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Joseph Kamtchum-TatueneMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Gloria Mwangalika KachingweMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Henry C MwandumbaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Tom SolomonInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Laura A BenjaminInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
University of Liverpool · GBUniversity of Alberta · CA

Funding

Department of Health IS-HPU-1112-10117Wellcome Trust
6 · The paper itself

Abstract

BACKGROUND AND

objectiveIn sub-Saharan Africa, data on prevalence, risk factors and pathobiology of carotid atherosclerosis are scarce. We aimed to investigate the relationship between biomarkers of endothelial dysfunction and carotid atherosclerosis.

methodsCarotid ultrasound was performed in 66 patients. Plasma concentration of ICAM-1, PAI-1, VEGF, and soluble thrombomodulin were measured by ELISA. A univariable logistic regression analysis was performed to study the relationship between carotid atherosclerosis, biomarkers of endothelial dysfunction, and various demographic and clinical parameters of the participants.

resultsThe mean age of the participants was 58.7 years (95% CI: 54.4-63.1). Carotid atherosclerosis was diagnosed in 39.4% (95% CI: 27.6-52.2). In the univariable logistic regression, the following factors were associated with carotid atherosclerosis: age > 45 years (OR = 12.0, 95% CI: 1.4-98.8,

conclusionsThere is an association between high levels of soluble thrombomodulin and carotid atherosclerosis in Malawian adults. Further studies with a larger sample size are needed to confirm our findings in other African populations.

Indexed as

AfricaAtherosclerosisCarotid intima-media thicknesscIMT, Carotid intima-media thicknessCV, Coefficient of variabilityELISA, Enzyme-linked immunosorbent assayEndothelial dysfunctionHIV, Human immunodeficiency virusHIV infectionICAM-1, Intercellular adhesion molecule 1PAI-1, Plasminogen activator inhibitor 1sTM, soluble thrombomodulinStrokeVEGF, Vascular endothelial growth factor

Identifiers

PMID32642566
PMCPMC7334363
OpenAlexW3037728938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.